Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection

Title
Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection
Authors
Keywords
regenerative medicine, cell therapy, immune rejection, immune evasion, stem cells, diabetes, pancreatic beta cells, human leukocyte antigens, beta cell replacement therapy
Journal
Cell Reports
Volume 36, Issue 7, Pages 109538
Publisher
Elsevier BV
Online
2021-08-17
DOI
10.1016/j.celrep.2021.109538

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started